This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 4, No 3 (2015): Jul-Sep

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Authors of this article:

Barbora de Courten1 Author Orcid Image ;   Maximilian PJ de Courten2 Author Orcid Image ;   Casper G Schalkwijk3 Author Orcid Image ;   Karen Z Walker4 Author Orcid Image ;   Josephine Forbes5, 6 Author Orcid Image
Article Authors Cited by (5) Tweetations (2) Metrics

Journals

  1. Baye E, de Courten M, Walker K, Ranasinha S, Earnest A, Forbes J, de Courten B. Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial. Scientific Reports 2017;7(1) View
  2. de Courten B, de Courten M, Soldatos G, Dougherty S, Straznicky N, Schlaich M, Sourris K, Chand V, Scheijen J, Kingwell B, Cooper M, Schalkwijk C, Walker K, Forbes J. Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial. The American Journal of Clinical Nutrition 2016;103(6):1426 View
  3. Adams J, Martelle S, Raffield L, Freedman B, Langefeld C, Hsu F, Maldjian J, Williamson J, Hugenschmidt C, Carr J, Cox A, Bowden D. Analysis of advanced glycation end products in the DHS Mind Study. Journal of Diabetes and its Complications 2016;30(2):262 View
  4. de Vos L, Lefrandt J, Dullaart R, Zeebregts C, Smit A. Advanced glycation end products: An emerging biomarker for adverse outcome in patients with peripheral artery disease. Atherosclerosis 2016;254:291 View
  5. Bui T. The Human Microbiome as a Therapeutic Target for Metabolic Diseases. Nutrients 2024;16(14):2322 View